Oncology · Nov 6, 2026
SENOLYSIS AS AN INNOVATIVE STRATEGY FOR THE SELECTIVE ELIMINATION OF SENESCENT CELLS: Part 1. Potential use of senolytics in the treatment of cancer patients
By Фільченков О
According to current understanding, cellular senescence is not a purely natural phenomenon but can be induced by numerous stress factors. Senescence, whether natural or induced, is characterized by stable and prolonged cell cycle arrest, reorganization of metabolic processes, secretion of factors that affect neighboring cells or act systemically, and loss of sensitivity to mitogenic or apoptotic signals. Various cell types, including tumor cells, can acquire these features. The accumulation of senescent tumor cells that have survived anticancer therapy may contribute to the development of drug resistance, chronic inflammation, the formation of new blood vessels to nourish the neoplasm, suppression of the antitumor immune response, and the formation of metastatic foci. To overcome the undesirable effects of senescent tumor cells, a new therapeutic approach based on the selective destruction of these cells, known as senolysis, has been proposed. The aim of this work was to critically analyze current data on the types of cellular senescence, the mechanisms of their development, and the main biomarkers of senescent cells. The review also examines the features of tumor cell senolysis and discusses the potential clinical use of senolytics in combination therapy for cancer patients.
doi.org/10.15407/oncology.2026.03.137Open accessInterventions